How is ER Low Used in Clinical Trials?
Clinical trials are studying the response of ER low tumors to hormone therapy. Visit the links to learn more.
Non-Treatment Trials: Predicting Response to Treatment and Decision Support
This month, we are highlighting trials that study ways to predict how tumors respond to treatment and help guide treatment decisions. Click to learn more and find these types of trials on Metastatic Trial Search.
Artificial Intelligence (AI) and MBC
AI (Artificial Intelligence) is being studied for its ability to improve clinical trials, predict response to treatment, and more. Read below to learn more about how AI may help people with MBC.
Meet the Clinical Trial Team: The Principal Investigator
We continue our series by highlighting the principal investigator, who is responsible for the overall management of the trial.
Living Beyond Breast Cancer Conference 2023
LBBC’s Thriving Together MBC conference was held from April 28-30, 2023. Click to view conference highlights and recordings.
Non-Treatment Trials: Managing Side Effects
This month, we are starting a series highlighting non-treatment (or non-interventional) trials, beginning with trials that study ways to prevent, reduce, or manage side effects.
Shared Decision-Making: Collaborating with Your Doctors About Your Cancer Care
Hear from experts about how to be more in control of your healthcare choices, based on risks, benefits, and your personal goals.
The Latest Research on Lobular MBC
Lobular MBC is harder to detect and spreads to different places in the body compared to ductal MBC. Click to learn more about recent research and clinical trials for lobular MBC.
What is the Microbiome and How Might it Affect MBC?
The microbiome is the community of bacteria, viruses, and fungi in your body. Learn about the microbiome and how it may affect MBC and treatment.
Miami Breast Cancer Conference 2023
Read MBC research highlights from the 2023 Miami Breast Cancer Conference.